Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
Open Access
- 27 March 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 49 (1), 117-125
- https://doi.org/10.1007/s00535-013-0793-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalClinical Cancer Research, 2012
- Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and OsteopontinAnnals of Surgical Oncology, 2011
- Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patientsMolecular Biology Reports, 2011
- Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaJournal of Hepatology, 2011
- Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomasJournal of Clinical Pathology, 2011
- Up-regulation of glypican-3 in human hepatocellular carcinoma.2010
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Hepatocellular carcinomaThe Lancet, 2003
- Glypican-3: a novel serum and histochemical marker for hepatocellular carcinomaGastroenterology, 2003
- Immunohistologic study on the expressions of [alpha ]-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinomaJournal of Hepatology, 2001